Clinical issues of mucus accumulation in COPD
- PMID: 24493923
- PMCID: PMC3908831
- DOI: 10.2147/COPD.S38938
Clinical issues of mucus accumulation in COPD
Abstract
Airway mucus is part of the lung's native immune function that traps particulates and microorganisms, enabling their clearance from the lung by ciliary transport and cough. Mucus hypersecretion and chronic productive cough are the features of the chronic bronchitis and chronic obstructive pulmonary disease (COPD). Overproduction and hypersecretion by goblet cells and the decreased elimination of mucus are the primary mechanisms responsible for excessive mucus in chronic bronchitis. Mucus accumulation in COPD patients affects several important outcomes such as lung function, health-related quality of life, COPD exacerbations, hospitalizations, and mortality. Nonpharmacologic options for the treatment of mucus accumulation in COPD are smoking cessation and physical measures used to promote mucus clearance. Pharmacologic therapies include expectorants, mucolytics, methylxanthines, beta-adrenergic receptor agonists, anticholinergics, glucocorticoids, phosphodiesterase-4 inhibitors, antioxidants, and antibiotics.
Keywords: chronic bronchitis; chronic obstructive pulmonary disease; mucus; sputum.
Figures



Comment in
-
Clinical issues of mucus accumulation in COPD.Int J Chron Obstruct Pulmon Dis. 2014 Mar 25;9:301-2. doi: 10.2147/COPD.S61797. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24741301 Free PMC article. No abstract available.
Similar articles
-
Clinical issues of mucus accumulation in COPD.Int J Chron Obstruct Pulmon Dis. 2014 Mar 25;9:301-2. doi: 10.2147/COPD.S61797. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24741301 Free PMC article. No abstract available.
-
Chronic bronchitis and chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2013 Feb 1;187(3):228-37. doi: 10.1164/rccm.201210-1843CI. Epub 2012 Nov 29. Am J Respir Crit Care Med. 2013. PMID: 23204254 Free PMC article. Review.
-
Impact of N-Acetylcysteine on Mucus Hypersecretion in the Airways: A Systematic Review.Int J Chron Obstruct Pulmon Dis. 2024 Oct 29;19:2347-2360. doi: 10.2147/COPD.S474512. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39493366 Free PMC article.
-
Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease.J Transl Int Med. 2015 Jun-Sep;3(3):89-92. doi: 10.1515/jtim-2015-0013. Epub 2015 Sep 30. J Transl Int Med. 2015. PMID: 27847895 Free PMC article. Review.
-
Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians.Int J Chron Obstruct Pulmon Dis. 2017 Mar 22;12:803-812. doi: 10.2147/COPD.S114423. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28405161 Free PMC article. Review.
Cited by
-
The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications.Curr Opin Pulm Med. 2015 Mar;21(2):133-41. doi: 10.1097/MCP.0000000000000145. Curr Opin Pulm Med. 2015. PMID: 25575367 Free PMC article. Review.
-
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis.Eur Respir Rev. 2023 Jan 25;32(167):220141. doi: 10.1183/16000617.0141-2022. Print 2023 Mar 31. Eur Respir Rev. 2023. PMID: 36697209 Free PMC article. Review.
-
Lung regeneration: a tale of mice and men.Semin Cell Dev Biol. 2020 Apr;100:88-100. doi: 10.1016/j.semcdb.2019.11.006. Epub 2019 Nov 21. Semin Cell Dev Biol. 2020. PMID: 31761445 Free PMC article. Review.
-
Antimicrobial and Anti-Inflammatory Activity of Apple Polyphenol Phloretin on Respiratory Pathogens Associated With Chronic Obstructive Pulmonary Disease.Front Cell Infect Microbiol. 2021 Nov 22;11:652944. doi: 10.3389/fcimb.2021.652944. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34881190 Free PMC article.
-
Respiratory dysbiosis and population-wide temporal dynamics in canine chronic bronchitis and non-inflammatory respiratory disease.PLoS One. 2020 Jan 28;15(1):e0228085. doi: 10.1371/journal.pone.0228085. eCollection 2020. PLoS One. 2020. PMID: 31990924 Free PMC article.
References
-
- Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. - PubMed
-
- World Health Organization . World Health Statistics 2008. Geneva, Switzerland: World Health Organization; 2008. [Accessed July 23, 2013]. Available from: http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf.
-
- Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 2009;135(2):505–512. - PubMed
-
- Shade D, Jr, Cordova FC. Normal lung structure. In: Criner GJ, D’Alonzo GE, editors. Pulmonary Pathophysiology. 1st ed. 1999. p. 20.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical